|
1
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goldstein DA, Zeichner SB, Bartnik CM,
Neustadter E and Flowers CR: Metastatic colorectal cancer: A
systematic review of the value of current therapies. Clin
Colorectal Cancer. 15:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji J, Xu R, Ding K, Bao G, Zhang X, Huang
B, Wang X, Martinez A, Wang X, Li G, et al: Long noncoding RNA
SChLAP1 forms a growth promoting complex with HNRNPL in human
glioblastoma through stabilization of ACTN4 and Activation of NF-κB
signaling. Clin Cancer Res. 25:6868–6881. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yao N, Fu Y, Chen L, Liu Z, He J, Zhu Y,
Xia T and Wang S: Long non-coding RNA NONHSAT101069 promotes
epirubicin resistance, migration, and invasion of breast cancer
cells through NONHSAT101069/miR-129-5p/Twist1 axis. Oncogene.
38:7216–7233. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng ZQ, Li ZX, Zhou GQ, Lin L, Zhang LL,
Lv JW, Huang XD, Liu RQ, Chen F, He XJ, et al: Long noncoding RNA
FAM225A promotes nasopharyngeal carcinoma tumorigenesis and
metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and
upregulate ITGB3. Cancer Res. 79:4612–4626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu P, Wu J, Wang Y, Zhu X, Lu T, Liu B,
He L, Ye B, Wang S, Meng S, et al: LncGata6 maintains stemness of
intestinal stem cells and promotes intestinal tumorigenesis. Nat
Cell Biol. 20:1134–1144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X,
Tian X, Guo F, Liang Q, Liu Q, et al: LncRNA GLCC1 promotes
colorectal carcinogenesis and glucose metabolism by stabilizing
c-Myc. Nat Commun. 10:34992019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang FW, Cao CH, Han K, Zhao YX, Cai MY,
Xiang ZC, Zhang JX, Chen JW, Zhong LP, Huang Y, et al:
APC-activated long noncoding RNA inhibits colorectal carcinoma
pathogenesis through reduction of exosome production. J Clin
Invest. 129:727–743. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lan Y, Xiao X, He Z, Luo Y, Wu C, Li L and
Song X: Long noncoding RNA OCC-1 suppresses cell growth through
destabilizing HuR protein in colorectal cancer. Nucleic Acids Res.
46:5809–5821. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamada A, Yu P, Lin W, Okugawa Y, Boland
CR and Goel A: A RNA-Sequencing approach for the identification of
novel long non-coding RNA biomarkers in colorectal cancer. Sci Rep.
8:5752018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sha QK, Chen L, Xi JZ and Song H: Long
non-coding RNA LINC00858 promotes cells proliferation, migration
and invasion by acting as a ceRNA of miR-22-3p in colorectal
cancer. Artif Cells Nanomed Biotechnol. 47:1057–1066. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Berg KCG, Eide PW, Eilertsen IA,
Johannessen B, Bruun J, Danielsen SA, Bjørnslett M, Meza-Zepeda LA,
Eknæs M, Lind GE, et al: Multi-omics of 34 colorectal cancer cell
lines-a resource for biomedical studies. Mol Cancer. 16:1162017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang D, Xu L, Zhang M, Dorfman RG, Pan Y,
Zhou Q, Zhou L, Wang Y, Li Y, Yin Y, et al: Metformin facilitates
BG45-induced apoptosis via an anti-Warburg effect in
cholangiocarcinoma cells. Oncol Rep. 39:1957–1965. 2018.PubMed/NCBI
|
|
17
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang JH, Li JH, Shao P, Zhou H, Chen YQ
and Qu LH: StarBase: A database for exploring microRNA-mRNA
interaction maps from argonaute CLIP-Seq and degradome-seq data.
Nucleic Acids Res. 39:D202–D209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu SP, Wang JY, Wang XG and Zhao JP: Long
intergenic non-protein coding RNA 00858 functions as a competing
endogenous RNA for miR-422a to facilitate the cell growth in
non-small cell lung cancer. Aging (Albany NY). 9:475–486. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue M, Shi D, Xu G and Wang W: The long
noncoding RNA linc00858 promotes progress of lung cancer through
miR-3182/MMP2 axis. Artif Cells Nanomed Biotechnol. 47:2091–2097.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gu Z, Hou Z, Zheng L, Wang X, Wu L and
Zhang C: Long noncoding RNA LINC00858 promotes osteosarcoma through
regulating miR-139-CDK14 axis. Biochem Biophys Res Commun.
503:1134–1140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sur S, Pagliarini R, Bunz F, Rago C, Diaz
LA Jr, Kinzler KW, Vogelstein B and Papadopoulos N: A panel of
isogenic human cancer cells suggests a therapeutic approach for
cancers with inactivated p53. Proc Natl Acad Sci USA.
106:3964–3969. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu JL, Rak JW, Coomber BL, Hicklin DJ and
Kerbel RS: Effect of p53 status on tumor response to antiangiogenic
therapy. Science. 295:1526–1528. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abu El Maaty MA, Strassburger W, Qaiser T,
Dabiri Y and Wolfl S: Differences in p53 status significantly
influence the cellular response and cell survival to
1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer
cells. Mol Carcinog. 56:2486–2498. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ulitsky I and Bartel DP: LincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao S, Sun H, Jiang W, Mi Y, Zhang D, Wen
Y, Cheng D, Tang H, Wu S, Yu Y, et al: miR-4775 promotes colorectal
cancer invasion and metastasis via the Smad7/TGFβ-mediated
epithelial to mesenchymal transition. Mol Cancer. 16:122017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Simone V, Bevivino G, Sedda S, Izzo R,
Laudisi F, Dinallo V, Franzè E, Colantoni A, Ortenzi A, Salvatori
S, et al: Smad7 knockdown activates protein kinase RNA-associated
eIF2α pathway leading to colon cancer cell death. Cell Death Dis.
8:e26812017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang H, Nie L, Wu L, Liu Q and Guo X:
NR2F2 inhibits Smad7 expression and promotes TGF-β-dependent
epithelial- mesenchymal transition of CRC via transactivation of
miR-21. Biochem Biophys Res Commun. 485:181–188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakao A, Afrakhte M, Morén A, Nakayama T,
Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH
and ten Dijke P: Identification of Smad7, a TGFbeta-inducible
antagonist of TGF-beta signalling. Nature. 389:631–635. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hayashi H, Abdollah S, Qiu Y, Cai J, Xu
YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL
and Falb D: The MAD-related protein Smad7 associates with the
TGFbeta receptor and functions as an antagonist of TGFbeta
signaling. Cell. 89:1165–1173. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kavsak P, Rasmussen RK, Causing CG, Bonni
S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an
E3 ubiquitin ligase that targets the TGF beta receptor for
degradation. Mol Cell. 6:1365–1375. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shi W, Sun C, He B, Xiong W, Shi X, Yao D
and Cao X: GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta
type I receptor. J Cell Biol. 164:291–300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Butz H, Racz K, Hunyady L and Patocs A:
Crosstalk between TGF-β signaling and the microRNA machinery.
Trends Pharmacol Sci. 33:382–393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boguslawska J, Rodzik K, Poplawski P,
Kędzierska H, Rybicka B, Sokół E, Tański Z and Piekiełko-Witkowska
A: TGF-β1 targets a microRNA network that regulates cellular
adhesion and migration in renal cancer. Cancer Lett. 412:155–169.
2018. View Article : Google Scholar : PubMed/NCBI
|
